Keywords: rxkinetix, starts, phase, ii, mucositis, trials, colorado

RxKinetix starts Phase II mucositis trials

Article | 27 January 2003

Print This

Colorado, USA-based RxKinetix has begun patient enrollment in a PhaseII clinical trial of RK-0202 in oral mucositis, a painful and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in